The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Clinical events beyond one year after an acute coronary syndrome: insights from the RECLOSE 2-ACS study

EuroIntervention 2017;12:2018-2024. DOI: 10.4244/EIJ-D-16-00255

1. Cardiovascular and Thoracic Department, Careggi University Hospital, Florence, Italy; 2. Cardiovascular and Thoracic Department, Padua University, Padua, Italy

Aims: The optimal duration of dual antiplatelet therapy after an acute coronary syndrome (ACS) is still unknown and debated. We sought to assess the incidence of adverse clinical events b

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Does acute coronary syndrome impact on the incidence of thrombosis after the implantation of an Absorb bioresorbable vascular scaffold?